Glibornuride
From Infogalactic: the planetary knowledge core
Names | |
---|---|
IUPAC name
1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
|
|
Identifiers | |
26944-48-9 | |
ChemSpider | 16735831 |
DrugBank | DB08962 |
EC Number | 248-124-6 |
Jmol 3D model | Interactive image |
KEGG | D02427 |
MeSH | C073323 |
PubChem | 33649 |
UNII | VP83E7434R |
|
|
|
|
Properties | |
C18H26N2O4S | |
Molar mass | 366.48 g/mol |
Pharmacology | |
ATC code | A10 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
Synthesis
Gliburnide is an endo-endo derivative made from camphor-3-carboxamode by borohydride reduction (exo approach), followed by Hofmann rearrangement to carbamate, followed by displacement with sodium tosylamide.
References
<templatestyles src="Asbox/styles.css"></templatestyles>